Standard Process Ashwagandha 1:1 Review

by Standard Process
June 9, 2014BRS Publishing
Print Friendly

Is Standard Process Ashwagandha 1:1 Right For You?

Standard Process Ashwagandha 1:1 represents a tonic remedy that should offer adaptogenic effects to the entire body. The business that currently produces and sells this product is called Standard Processes. They mention several particular benefits that include an overall feeling of well-being, encouraging a healthy response towards environmental stress, supporting the body through the aging processes, as well as promoting a proper blood production. In addition, this supplement is advertised as a promoter of development and growth within normal parameters in children.

The business sells and manufactures more than three hundred products around the world, among which there are veterinary products, dietary supplements, and herbal solutions. It prides itself by having more than eighty years of experience on the nutritional market. Standard Process Ashwagandha 1:1 is recommended both for adult and children usage. However, lactating or pregnant women shouldn’t consider following this treatment before consulting a specialist.

The product’s effectiveness relies on the positive actions of a mixture between Withania Somnifera and Ashwagandha, both ancient Indian herbal extracts with known stress relief and anxiety lowering qualities. However, further clinical research is required in order to determine these effects in a general way, thus potential clients may only rely on previous testimonials and some clinical studies that have already been done.

Ingredients of Standard Process Ashwagandha 1:1

Standard Process Ashwagandha 1:1 contains the following ingredients: Ashwaganda root 1:1 extract from Withania Somnifera root 5.0g containing withanolides 10mg, Purified water, and 45% alcohol.

Add a Review

*Do Not Include Links In Your Comments Below or It Will Not Be Posted.
*Please keep your review/questions positive as they will be moderated for language and content before being approved.